1Section of Gastroenterology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
2Manitoba Inflammatory Bowel Disease Research Centre, Winnipeg, Manitoba, Canada
3Department of Radiology, University of Manitoba, Winnipeg, Manitoba, Canada
4Section of Nuclear Medicine, Health Sciences Centre, Winnipeg, Manitoba, Canada
5Department of Mechanical Engineering, University of Manitoba, Winnipeg, Manitoba, Canada
6Graduate Program in Biomedical Engineering, University of Manitoba, Winnipeg, Manitoba, Canada
7Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
Correspondence: Laura E. Targownik, MD, MSHS, Department of Internal Medicine, University of Manitoba, Manitoba Inflammatory Bowel Disease Research Centre, 805G-715 McDermot Avenue, Winnipeg, Manitoba, R3E 3P4, Canada. E-mail: [email protected]
Guarantor of the article: Laura Targownik, MD, MSHS.
Specific author contributions: All Authors were responsible for: planning and conducting the study, collecting and interpreting data, and drafting the manuscript. For each author, there should also be a statement. All authors have approved the final version of this manuscript.
Financial support: This research was supported by a Canadian Institutes of Health Research Priority Award in Osteoporosis.
Potential competing interests: Laura Targownik: Received Investigator Initiated Grant Support from Abbvie Canada, Janssen Canada and Pfizer Canada. Attended Advisory Boards for Takeda Canada, Janssen Canada, and Pfizer Canada, Speakers’ Panels for Takeda Canada, Janssen Canada. William Leslie: Has served as a speaker for Amgen, Eli Lily, and Novartis, and has received research grants from Amgen. Yunhua Luo, Andrew Goertzen: none.
